ANRO — ALTO NEUROSCIENCE INC
As of Q2 2026, 28 SEC-registered investment managers reported holding ANRO (ALTO NEUROSCIENCE INC) in their latest 13F filings, with a combined reported value of $180.11M across 7.18M shares. That is +32.7% by share count (+1.77M shares) versus the previous quarter, while reported value moved +58.9%. Ownership is concentrated: the five largest holders account for 73.3% of reported value and the top ten for 91.1%.
Compared with the prior quarter, 5 opened new positions, 12 added to existing stakes, 8 trimmed, 3 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
ANRO is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 2.12M | $55.97M | 0.00% | Add |
| Franklin Resources history | Q2 2026 | 1.01M | $26.74M | 0.01% | Reduce |
| Vanguard Group history | Q4 2025 | 1.37M | $24.31M | 0.00% | Add |
| Geode Capital Management history | Q2 2026 | 678.20K | $17.90M | 0.00% | Add |
| Northern Trust Corp history | Q2 2026 | 632.70K | $16.70M | 0.00% | Add |
| Millennium Management history | Q2 2026 | 558.32K | $14.73M | 0.01% | Reduce |
| Point72 Asset Management history | Q2 2026 | 502.95K | $13.27M | 0.01% | Hold |
| Goldman Sachs Group history | Q2 2026 | 236.83K | $6.25M | 0.00% | Add |
| Marshall Wace history | Q2 2026 | 225.50K | $5.95M | 0.01% | Add |
| Two Sigma Investments history | Q2 2026 | 147.30K | $3.89M | 0.00% | Reduce |
| Alkeon Capital Management history | Q2 2026 | 102.10K | $2.69M | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2026 | 80.58K | $2.13M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 76.33K | $2.01M | 0.00% | New |
| Morgan Stanley history | Q2 2026 | 74.94K | $1.98M | 0.00% | Add |
| Renaissance Technologies history | Q2 2026 | 71.40K | $1.88M | 0.00% | Reduce |
| Wellington Management Group history | Q2 2026 | 70.91K | $1.87M | 0.00% | Add |
| UBS Group AG history | Q2 2026 | 58.70K | $1.55M | 0.00% | Add |
| D. E. Shaw & Co history | Q1 2026 | 45.34K | $1.02M | 0.00% | Reduce |
| Norges Bank Investment Management history | Q2 2024 | 76.67K | $819.62K | 0.00% | New |
| Manulife Financial history | Q2 2026 | 30.23K | $797.85K | 0.00% | Add |
New Positions (Q2 2026)
- BNY Mellon 76.33K sh · $2.01M
- Deutsche Bank AG 26.05K sh · $687.49K
- Invesco Ltd 14.26K sh · $376.19K
- JPMorgan Chase & Co 10.90K sh · $306.07K
- Legal & General Investment Management America 2.54K sh · $67.11K
Fully Exited (vs previous quarter)
- D. E. Shaw & Co sold 45.34K sh · $1.02M
- Balyasny Asset Management sold 32.11K sh · $721.86K
- Polen Capital Management sold 16.61K sh · $373.46K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | — | — | 1.45M | 1.48M | 1.46M | 561.85K | 367.88K | 607.87K | 666.19K | 2.12M |
| Franklin Resources | 625.01K | 625.04K | 1.22M | 1.16M | 1.16M | 1.16M | 1.16M | 1.12M | 1.10M | 1.01M |
| Geode Capital Management | 86.14K | 188.97K | 469.99K | 472.66K | 486.86K | 229.72K | 237.90K | 287.44K | 292.90K | 678.20K |
| Northern Trust Corp | 16.39K | 21.03K | 196.94K | 587.13K | 589.28K | 463.34K | 461.29K | 474.37K | 473.40K | 632.70K |
| Millennium Management | 119.22K | 16.84K | 32.30K | — | 16.18K | 302.86K | 315.76K | 629.99K | 821.98K | 558.32K |
| Point72 Asset Management | 1.12M | 1.05M | 977.69K | 1.69M | 1.24M | 1.33M | 1.33M | 1.61M | 503.09K | 502.95K |
| Goldman Sachs Group | — | 14.15K | 45.54K | 111.28K | 100.37K | 166.09K | 90.25K | 156.32K | 104.72K | 236.83K |
| Marshall Wace | 21.29K | — | — | 837.37K | 852.99K | 937.41K | 825.23K | 193.11K | 176.35K | 225.50K |
| Two Sigma Investments | — | — | 12.94K | 30.70K | 26.14K | 44.73K | 116.58K | 140.32K | 216.10K | 147.30K |
| Alkeon Capital Management | — | 934.90K | 934.90K | 477.10K | 477.10K | 477.10K | 477.10K | 477.10K | 227.10K | 102.10K |
| Charles Schwab Investment Management | 45.03K | 66.19K | 186.97K | 154.83K | 150.42K | 115.26K | — | 17.06K | 17.02K | 80.58K |
| BNY Mellon | — | 23.56K | 45.46K | 52.27K | 49.55K | — | — | — | — | 76.33K |
| Morgan Stanley | 13.29K | 26.32K | 76.16K | 202.64K | 46.81K | 64.63K | 61.04K | 65.58K | 68.65K | 74.94K |
| Renaissance Technologies | — | — | — | — | — | 34.70K | 75.77K | 97.40K | 103.50K | 71.40K |
| Wellington Management Group | — | — | 60.64K | 77.15K | — | — | — | 69.02K | 59.80K | 70.91K |
| UBS Group AG | 867 | 2.69K | 35.01K | 402.40K | 510.21K | 428.22K | 139.03K | 18.49K | 17.25K | 58.70K |
| Manulife Financial | 35.67K | 35.67K | 65.81K | 62.39K | — | — | — | — | 23.75K | 30.23K |
| Wells Fargo & Co | 65 | 3.26K | 7.85K | 10.99K | 11.24K | 351 | — | 765 | 790 | 26.30K |
| Deutsche Bank AG | — | — | 11.58K | 15.21K | 15.21K | — | — | — | — | 26.05K |
| Citigroup Inc | 33.84K | 1.95K | 15.47K | 16.85K | 15.14K | 2.30K | — | 12.57K | 9.43K | 20.75K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details